Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14001 - 14025 of 14503 in total
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Displaying drugs 14001 - 14025 of 14503 in total